Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections

Roberto Giurazza,Maria Civita Mazza,Roberto Andini,Pasquale Sansone,Maria Caterina Pace,Emanuele Durante-Mangoni

DOI: https://doi.org/10.3390/life11060519

2021-06-03

Life

Abstract:Antimicrobial resistance (AMR) remains one of the top public health issues of global concern. Among the most important strategies for AMR control there is the correct and appropriate use of antibiotics, including those available for the treatment of AMR pathogens. In this article, after briefly reviewing the most important and clinically relevant multi-drug-resistant bacteria and their main resistance mechanisms, we describe the emerging antimicrobial options for both MDR Gram-positive cocci and Gram-negative bacilli, including recently marketed agents, molecules just approved or under evaluation and rediscovered older antibiotics that have regained importance due to their antimicrobial spectrum. Specifically, emerging options for Gram-positive cocci we reviewed include ceftaroline, ceftobiprole, tedizolid, dalbavancin, and fosfomycin. Emerging treatment options for Gram-negative bacilli we considered comprise ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, aztreonam-avibactam, minocycline, fosfomycin, eravacycline, plazomicin, and cefiderocol. An exciting scenario is opening today with the long awaited growing availability of novel molecules for the treatment of AMR bacteria. Knowledge of mechanisms of action and resistance patterns allows physicians to increasingly drive antimicrobial treatment towards a precision medicine approach. Strict adherence to antimicrobial stewardship practices will allow us to preserve the emerging antimicrobials for our future.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the treatment options for multi - drug - resistant bacterial infections. Specifically, the article mainly focuses on emerging antibacterial treatment options for multi - drug - resistant (MDR) bacteria, especially Gram - positive cocci and Gram - negative bacilli. It is mentioned in the paper that antimicrobial resistance (AMR) is one of the important issues in global public health, and the correct and appropriate use of antibiotics is one of the key strategies to control AMR. After briefly reviewing the most important and clinically relevant multi - drug - resistant bacteria and their main resistance mechanisms, the article describes emerging antibacterial drugs against these bacteria, including recently marketed drugs, newly approved or under - evaluation molecules, and older antibiotics that have regained importance due to their antibacterial spectra.

### Main problems
1. **Treatment of multi - drug - resistant bacteria**:
- **Background**: Antimicrobial resistance (AMR) is a major issue in global public health, especially the emergence and spread of multi - drug - resistant bacteria.
- **Objective**: To explore and summarize new treatment methods for multi - drug - resistant bacteria, especially new antibacterial drugs for Gram - positive cocci and Gram - negative bacilli.

### Specific content
- **Gram - positive cocci**:
- **Existing treatment options**: Daptomycin, Linezolid, etc.
- **Emerging treatment options**: Ceftobiprole, Ceftaroline, Tedizolid, Dalbavancin, Fosfomycin, etc.

- **Gram - negative bacilli**:
- **Existing treatment options**: Polymyxin, Tigecycline, etc.
- **Emerging treatment options**: Ceftazidime - Avibactam, Meropenem - Vaborbactam, Imipenem - Relebactam, Aztreonam - Avibactam, Minocycline, Fosfomycin, Eravacycline, Plazomicin, Cefiderocol, etc.

### Purposes
- **Provide new treatment options**: To introduce and evaluate newly marketed or即将上市的 antibacterial drugs to meet the challenges of multi - drug - resistant bacteria.
- **Promote precision medicine**: By understanding the mechanisms of action and resistance patterns of these new drugs, help doctors select and use antibacterial drugs more precisely.
- **Emphasize antimicrobial stewardship**: Emphasize the importance of strict compliance with antimicrobial stewardship practices to protect the effectiveness of emerging antibacterial drugs.

### Conclusion
The article aims to provide more treatment options for clinicians by reviewing emerging antibacterial drugs to deal with the increasingly serious problem of multi - drug - resistant bacterial infections. At the same time, it emphasizes the importance of rational use of antibacterial drugs to prolong the有效期 of these new drugs.